Evidence for the Biosynthesis of DHEA from Cholesterol by First-Trimester Human Placental Tissue: Source of Androgens

Abstract

With a view to establishing whether first-trimester human placentas possess the ability to synthesize DHEA from cholesterol, homogenates of this tissue obtained from two groups of women undergoing elective termination of normally progressing pregnancy between 10 - 12 weeks gestation (n = 5, age 23 - 29 years and n = 5, age 21 - 27 years) were incubated separately with [26-¹⁴C]cholesterol for the generation of [¹⁴C]isocaproic acid + pregnenolone and [7n-³H]pregnenolone for the biosynthesis of [³H]DHEA. Controls consisted of homogenates heated in a boiling water bath for 10 min. Using the reverse-isotope dilution analysis, desmolase efficiency expressed as mean specific activity of [¹⁴C]isocaproic acid varied from 282 to 725 dpm/mmol, while that of 17α-hydroxylase and steroid C-17,20-lyase, catalyzed conversion of [7n-³H]pregnenolone to [³H]DHEA varied from 3498 to 26 258 dpm/mmol. The corresponding efficiencies of enzymicconversion varied between 5.8 × 10 ^-2 and 1.5 × 10 ^-1 % for [¹⁴C]isocaproic acid, but between 5.5 × 10 ^-2 and 4.1 × 10 ^-1 % for [³H]DHEA. No such metabolite was evident in the controls of heat-denatured homogenates. These are the first study results to demonstrate that early placentas are capable of converting cholesterol to pregnenolone to DHEA, contrary to the widely held concept of DHEA production by fetal and maternal adrenal glands. This finding has important physiological implications and could provide a new dimension to the concept of fetoplacental steroidogenesis.

Key words

Cholesterol Cleavage - Pregnenolone Formation - DHEA Synthesis - Early Placenta - Fetoplacental Steroidogenesis

References

• 1 Winkel C A, Snyder J M, MacDonald P C, Simpson E R. Regulation of cholesterol and progesterone synthesis in human placental cells in culture by serum lipoproteins.  Endocrinology. 1980;  106 1054-1060
• 2 Dubois R N, Simpson E R, Kramer R E, Waterman M R. Induction of synthesis of cholesterol side-chain cleavage cytochrome P450 by adrenocorticotropin in cultured bovine adrenocortical cells.  J Biol Chem. 1981;  256 7000-7005
• 3 Simpson E R, Miller W L. Cholesterol side-chain cleavage, cytochrome P450, and iron-sulfur protein in human placental mitochondria.  Arch Biochem Biophys. 1978;  190 800-808
• 4 Simpson E R, MacDonald P C. Endocrine physiology of the placenta.  Ann Rev Physiol. 1981;  43 163-188
• 5 Diczfalusy E. Steroid metabolism in the human fetoplacental unit.  Acta Endocrinol (kbh). 1969;  61 649-664
• 6 Miller W L. Steroid hormone biosynthesis and actions in the materno-feto-placental unit.  Clin Perinatol. 1998;  25 799-817
• 7 Voutilainen R, Ilvesmaki V, Miettinen P J. Low expression of 3β-hydroxy-5-ene steroid dehydrogenase gene in human fetal adrenal glands in vivo. Adrenocorticotropin and protein kinase C-dependent regulation in adrenocortical cultures.  J Clin Endocrinol Metab. 1991;  72 761-767
• 8 Gunasegaram R, Peh K L, Loganath A, Ng S C, Kottegoda S R, Ratnam S S. Identification of a Δ⁵-3-beta hydroxy pathway of androgen biosynthesis in term human fetal amnion.  IRCS Med Sci. 1986;  14 150-151
• 9 Peh K L, Gunasegaram R, Loganath A, Ng S C, Kottegoda S R, Ratnam S S. Biosynthesis of dehydroepiandrosterone by term human fetal chorion in vitro.  Horm Metab Res. 1987;  19 231-232
• 10 Loganath A, Gunasegaram R, Peh K L, Chow W P, Chew P CT, Ratnam S S. In vitro formation of testosterone via the Δ⁵-pathway in the human umbilical cord.  Steroids. 1992;  57 189-192
• 11 Gunasegaram R, Peh K L, Loganath A, Chew P CT, Ratnam S S, Arulkumaran S. Cytochrome P-450 cholesterol side-chain cleavage expression in human spermatozoa.  Horm Metab Res. 1998;  30 58-60
• 12 Kessler M J. Liquid Scintillation Analysis, Science and Technology.  Meriden Packard Instrument. 1989;  5.1-5.18
• 13 Tuckey R C, Cameron K J. Human placental cholesterol side-chain cleavage: enzymatic synthesis of (22R)-20 alpha, 22-dihydroxycholesterol.  Steroids. 1993;  58 230-233
• 14 Miller W L. Mitochondrial specificity of the early steps in steroidogenesis.  J Steroid Biochem Mol Biol. 1995;  55 607-616
• 15 Strauss J F, Martinez F, Kiriakidou M. Placental steroid hormone synthesis: Unique features and unanswered questions.  Biol Reprod. 1996;  54 303-311
• 16 Tuckey R C, Woods S T, Tajbakhsh M. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain cleavage activity in the human placenta.  Eur J Biochem. 1997;  244 835-839
• 17 Tuckey R C, Sadleir J. The concentration of adrenodoxin reductase limits cytochrome P450scc activity in the human placenta.  Eur J Biochem. 1999;  263 319-325
• 18 Siiteri P K, MacDonald P C. Placental estrogen biosynthesis during human pregnancy.  J Clin Endocrinol Metab. 1966;  26 751-761
• 19 Pion R, Jaffe R, Eriksson G, Wiqvist N, Diczfalusy E. Studies on the metabolism of C-21 steroids in the human foetoplacental unit. I. Formation of α,β-unsaturated 3-ketones in midterm placentas perfused in situ with pregnenolone and 17α-hydroxypregnenolone.  Acta Endocrinol (kbh). 1965;  48 234-238
• 20 Khorram O. DHEA: a hormone with multiple effects.  Curr Opin Obstet Gynecol. 1996;  8 351-354
• 21 Marks P A, Banks J A. Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids.  Proc Natl Acad Sci USA. 1960;  46 447-452
• 22 Coleman D L, Letter E H, Schwizer R W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.  Diabetes. 1982;  31 830-833
• 23 Suitters A J, Shaw S, Wales M R, Porter J R, Leonard J, Woodger R, Brand H, Bodmer M, Foulkes R. Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase.  Immunology. 1997;  91 314-321
• 24 Nestler J E, Clore J N, Blackward W G. Dehydroepiandrosterone: The ”missing link“ between hyperinsulinemia and atherosclerosis.  FASEB J. 1992;  6 3073-3075
• 25 Byrne J J, Bradlow H L. DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.  Diabetes Technol Ther. 2001;  3 211-219
• 26 Falcone T, Finegood D T, Fantus I G, Morris D. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.  J Clin Endocrinol Metab. 1990;  71 1653-1657
• 27 Ueshiba H, Tsuboi K, Miyachi Y. Effects of amlodipine on serum levels of adrenal androgens and insulin in hypertensive men with obesity.  Horm Metab Res. 2001;  33 167-169
• 28 Beer N A, Jakubowicz D, Beer R M, Arocha I R, Nestler J E. Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.  J Clin Endocrinol Metab. 1993;  76 1464-1469
• 29 Manabe A, Hata T, Yanagihara T, Hashimoto M, Yamada Y, Irikomas S, Aoki S, Masumura S, Miyazaki K. Nitric oxide synthesis is increased after dehydroepiandrosterone sulphate administration in term human pregnancy.  Hum Reprod. 1999;  14 2116-2119
• 30 Belayet H M, Kanayama N, Khatun S, Tokunaga N, Sugimura M, Yamashita M, Kobayashi T, Terao T. Dehydroepiandrosterone sulphate promotes hyaluronic acid-induced cervical ripening in rabbits.  Hum Reprod. 1999;  14 1361-1367
• 31 Henderson E, Yang J Y, Schwartz A. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-I III B replication AIDS.  Res Hum Retro viruses. 1992;  8 625-631
• 32 de Decker P, de Meirleir K, Joos E, Campine I, van Steenberge E, Smitz J, Velkeniers B. Dehydroepiandrosterone (DHEA) response to i. v. ACTH in patients with chronic fatigue sydrome.  Horm Metab Res. 1999;  31 18-21